122 research outputs found
The Sound Generated by Mid-Ocean Ridge Black Smoker Hydrothermal Vents
Hydrothermal flow through seafloor black smoker vents is typically turbulent and vigorous, with speeds often exceeding 1 m/s. Although theory predicts that these flows will generate sound, the prevailing view has been that black smokers are essentially silent. Here we present the first unambiguous field recordings showing that these vents radiate significant acoustic energy. The sounds contain a broadband component and narrowband tones which are indicative of resonance. The amplitude of the broadband component shows tidal modulation which is indicative of discharge rate variations related to the mechanics of tidal loading. Vent sounds will provide researchers with new ways to study flow through sulfide structures, and may provide some local organisms with behavioral or navigational cues
Is the left-right scale a valid measure of ideology? Individual-level variation in associations with "left" and "right" and left-right self-placement
In order to measure ideology, political scientists heavily rely on the so-called left-right scale. Left and right are, however, abstract political concepts and may trigger different associations among respondents. If these associations vary systematically with other variables this may induce bias in the empirical study of ideology. We illustrate this problem using a unique survey that asked respondents open-ended questions regarding the meanings they attribute to the concepts "left" and "right". We assess and categorize this textual data using topic modeling techniques. Our analysis shows that variation in respondentsβ associations is systematically related to their self-placement on the left-right scale and also to variables such as education and respondentsβ cultural background (East vs. West Germany). Our ο¬ndings indicate that the interpersonal comparability of the left-right scale across individuals is impaired. More generally, our study suggests that we need more research on how respondents interpret various abstract concepts that we regularly use in survey questions
Systematic Genetic Nomenclature for Type VII Secretion Systems
CITATION: Bitter, W., et al. 2009. Systematic genetic nomenclature for type VII secretion systems. PLoS Pathogens, 5(10): 1-6, doi: 10.1371/journal.ppat.1000507.The original publication is available at http://journals.plos.org/plospathogensMycobacteria, such as the etiological
agent of human tuberculosis, Mycobacterium
tuberculosis, are protected by an impermeable
cell envelope composed of an inner
cytoplasmic membrane, a peptidoglycan
layer, an arabinogalactan layer, and an
outer membrane. This second membrane
consists of covalently linked, tightly packed
long-chain mycolic acids [1,2] and noncovalently
bound shorter lipids involved in
pathogenicity [3β5]. To ensure protein
transport across this complex cell envelope,
mycobacteria use various secretion pathways,
such as the SecA1-mediated general
secretory pathway [6,7], an alternative
SecA2-operated pathway [8], a twin-arginine
translocation system [9,10], and a
specialized secretion pathway variously
named ESAT-6-, SNM-, ESX-, or type
VII secretion [11β16]. The latter pathway,
hereafter referred to as type VII secretion
(T7S), has recently become a large and
competitive research topic that is closely
linked to studies of hostβpathogen interactions
of M. tuberculosis [17] and other
pathogenic mycobacteria [16]. Molecular
details are just beginning to be revealed
[18β22] showing that T7S systems are
complex machineries with multiple components
and multiple substrates. Despite
their biological importance, there has been
a lack of a clear naming policy for the
components and substrates of these systems.
As there are multiple paralogous T7S
systems within the Mycobacteria and
orthologous systems in related bacteria,
we are concerned that, without a unified
nomenclature system, a multitude of redundant
and obscure gene names will be
used that will inevitably lead to confusion
and hinder future progress. In this opinion
piece we will therefore propose and introduce
a systematic nomenclature with
guidelines for name selection of new
components that will greatly facilitate
communication and understanding in this
rapidly developing field of research.http://journals.plos.org/plospathogens/article?id=10.1371%2Fjournal.ppat.1000507Publisher's versio
Genome-Wide Screen for Mycobacterium tuberculosis Genes That Regulate Host Immunity
In spite of its highly immunogenic properties, Mycobacterium tuberculosis (Mtb) establishes persistent infection in otherwise healthy individuals, making it one of the most widespread and deadly human pathogens. Mtb's prolonged survival may reflect production of microbial factors that prevent even more vigorous immunity (quantitative effect) or that divert the immune response to a non-sterilizing mode (qualitative effect). Disruption of Mtb genes has produced a list of several dozen candidate immunomodulatory factors. Here we used robotic fluorescence microscopy to screen 10,100 loss-of-function transposon mutants of Mtb for their impact on the expression of promoter-reporter constructs for 12 host immune response genes in a mouse macrophage cell line. The screen identified 364 candidate immunoregulatory genes. To illustrate the utility of the candidate list, we confirmed the impact of 35 Mtb mutant strains on expression of endogenous immune response genes in primary macrophages. Detailed analysis focused on a strain of Mtb in which a transposon disrupts Rv0431, a gene encoding a conserved protein of unknown function. This mutant elicited much more macrophage TNFΞ±, IL-12p40 and IL-6 in vitro than wild type Mtb, and was attenuated in the mouse. The mutant list provides a platform for exploring the immunobiology of tuberculosis, for example, by combining immunoregulatory mutations in a candidate vaccine strain
Projected sensitivity of the LUX-ZEPLIN experiment to the two-neutrino and neutrinoless double Ξ² decays of Xe 134
The projected sensitivity of the LUX-ZEPLIN (LZ) experiment to two-neutrino and neutrinoless double Ξ² decay of Xe134 is presented. LZ is a 10-tonne xenon time-projection chamber optimized for the detection of dark matter particles and is expected to start operating in 2021 at Sanford Underground Research Facility, USA. Its large mass of natural xenon provides an exceptional opportunity to search for the double Ξ² decay of Xe134, for which xenon detectors enriched in Xe136 are less effective. For the two-neutrino decay mode, LZ is predicted to exclude values of the half-life up to 1.7Γ1024 years at 90% confidence level (CL) and has a three-sigma observation potential of 8.7Γ1023 years, approaching the predictions of nuclear models. For the neutrinoless decay mode LZ, is projected to exclude values of the half-life up to 7.3Γ1024 years at 90% CL
Cosmogenic production of {37}^Ar in the context of the LUX-ZEPLIN experiment
We estimate the amount of {37}^Ar produced in natural xenon via cosmic-ray-induced spallation, an inevitable consequence of the transportation and storage of xenon on the Earthβs surface. We then calculate the resulting {37}^Ar concentration in a 10-tonne payload (similar to that of the LUX-ZEPLIN experiment) assuming a representative schedule of xenon purification, storage, and delivery to the underground facility. Using the spallation model by Silberberg and Tsao, the sea-level production rate of {37}^Ar in natural xenon is estimated to be 0.024 atoms/kg/day. Assuming the xenon is successively purified to remove radioactive contaminants in 1-tonne batches at a rate of 1 tonne/month, the average {37}^Ar activity after 10 tons are purified and transported underground is 0.058 - 0.090 ΞΌ Bq/kg, depending on the degree of argon removal during above-ground purification. Such cosmogenic {37}^Ar will appear as a noticeable background in the early science data, while decaying with a 35-day half-life. This newly noticed production mechanism of {37}^Ar should be considered when planning for future liquid-xenon-based experiments
Phosphodiesterase-4 Inhibition Alters Gene Expression and Improves Isoniazid β Mediated Clearance of Mycobacterium tuberculosis in Rabbit Lungs
Tuberculosis (TB) treatment is hampered by the long duration of antibiotic therapy required to achieve cure. This indolent response has been partly attributed to the ability of subpopulations of less metabolically active Mycobacterium tuberculosis (Mtb) to withstand killing by current anti-TB drugs. We have used immune modulation with a phosphodiesterase-4 (PDE4) inhibitor, CC-3052, that reduces tumor necrosis factor alpha (TNF-Ξ±) production by increasing intracellular cAMP in macrophages, to examine the crosstalk between host and pathogen in rabbits with pulmonary TB during treatment with isoniazid (INH). Based on DNA microarray, changes in host gene expression during CC-3052 treatment of Mtb infected rabbits support a link between PDE4 inhibition and specific down-regulation of the innate immune response. The overall pattern of host gene expression in the lungs of infected rabbits treated with CC-3052, compared to untreated rabbits, was similar to that described in vitro in resting Mtb infected macrophages, suggesting suboptimal macrophage activation. These alterations in host immunity were associated with corresponding down-regulation of a number of Mtb genes that have been associated with a metabolic shift towards dormancy. Moreover, treatment with CC-3052 and INH resulted in reduced expression of those genes associated with the bacterial response to INH. Importantly, CC-3052 treatment of infected rabbits was associated with reduced ability of Mtb to withstand INH killing, shown by improved bacillary clearance, from the lungs of co-treated animals compared to rabbits treated with INH alone. The results of our study suggest that changes in Mtb gene expression, in response to changes in the host immune response, can alter the responsiveness of the bacteria to antimicrobial agents. These findings provide a basis for exploring the potential use of adjunctive immune modulation with PDE4 inhibitors to enhance the efficacy of existing anti-TB treatment
- β¦